Gram-Negative Bloodstream Infection Oral Antibiotic Therapy Trial

NARecruitingINTERVENTIONAL
Enrollment

1,204

Participants

Timeline

Start Date

February 22, 2024

Primary Completion Date

May 31, 2027

Study Completion Date

June 30, 2027

Conditions
Gram-negative Bacteremia
Interventions
DRUG

Intravenous Antibiotics

Participants will continue to receive intravenous antibiotics until the completion of the treatment course

DRUG

Oral Antibiotics

Participants will transition to oral antibiotics at the time of randomization and will continue oral antibiotics until the completion of the treatment course

Trial Locations (11)

19104

RECRUITING

Hospital of the University of Pennsylvania, Philadelphia

21202

RECRUITING

University of Maryland Medical Center, Baltimore

21287

RECRUITING

Johns Hopkins University Hospital Systems, Baltimore

24011

RECRUITING

Carilion Clinic, Roanoke

27710

RECRUITING

Duke University, Durham

37232

RECRUITING

Vanderbilt University Medical Center, Nashville

55905

RECRUITING

Mayo Clinic, Rochester

77030

RECRUITING

Houston Methodist, Houston

80204

RECRUITING

Denver Health Hospital Authority, Denver

94143

RECRUITING

University of California, San Francisco, San Francisco

08901

RECRUITING

Rutgers-RWJ University Hospital, New Brunswick

All Listed Sponsors
collaborator

Patient-Centered Outcomes Research Institute

OTHER

lead

Johns Hopkins University

OTHER